KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Current Assets (2016 - 2025)

Historic Current Assets for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $570.1 million.

  • Evolent Health's Current Assets rose 479.46% to $570.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $570.1 million, marking a year-over-year increase of 479.46%. This contributed to the annual value of $607.1 million for FY2024, which is 1119.78% down from last year.
  • Per Evolent Health's latest filing, its Current Assets stood at $570.1 million for Q3 2025, which was up 479.46% from $562.3 million recorded in Q2 2025.
  • Over the past 5 years, Evolent Health's Current Assets peaked at $727.9 million during Q1 2025, and registered a low of $393.8 million during Q3 2022.
  • Its 5-year average for Current Assets is $544.8 million, with a median of $524.0 million in 2021.
  • In the last 5 years, Evolent Health's Current Assets skyrocketed by 9665.88% in 2021 and then crashed by 1765.43% in 2022.
  • Quarter analysis of 5 years shows Evolent Health's Current Assets stood at $524.0 million in 2021, then dropped by 8.76% to $478.1 million in 2022, then skyrocketed by 43.01% to $683.7 million in 2023, then decreased by 11.2% to $607.1 million in 2024, then dropped by 6.1% to $570.1 million in 2025.
  • Its last three reported values are $570.1 million in Q3 2025, $562.3 million for Q2 2025, and $727.9 million during Q1 2025.